NFE2L2 and neoplasm: NRF2 pathway expression has been shown to contribute to radioresistance in many tumour types, in particular, lung cancer [8,9], SCC head and neck [10,11], oesophageal [12] and pancreas [13], and its mechanism extensively investigated [14].